AD patients have abnormal levels of ribosomal RNAs (rRNA18S, rRNA28S), ribosomal proteins (rpS5, rpS6, rpS10, rpS13), initiation factors (eIF3eta), and elongation factors (eEF1A, eEF2), suggesting aberrant protein synthesis. Here, RPS10 is linked to Alzheimer disease.